Practique Clinique et Investigation (Clinical Practice & Investigation) from June, 2019 is an International multidisciplinary, peer reviewed scholarly journal that provides an open access platform for the worldwide distribution of original and novel scientific manuscripts/articles based on the various aspects of the adept practical approaches to disease management. The priority of the journal is to publish manuscripts that provide useful insights into the real time efficacy and persisting lacunae in the various principles, tools and techniques involved in the diagnosis and treatment of acute and chronic diseases. The journal serve as a bond between the clinical and medical community and the general society by dispersing scientific advancements in medical and clinical research.
At this stage, the submission and publication of manuscripts is at huge discount for all students/emeritus professor. The published articles are made freely available to online readers.
Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC https://www.coronavirus.gov
Get the latest research https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Emmmanuel A Edafe
Azuonwu Obioma | Ihua Nnnena | Porokie Nekabari C
Amit Kumar | Sudhir Kumar Singh | Ritaj Kumar Rai | Abhishek Kumar
Nahla Shaaban Khalil
Bander Alkhudairi | Mohammed Alkarni
Jose Maria Pereira de Godoy | Francisco de Assis Cury | André Luís Baitelo| Maria de Fatima Guerreiro Godoy
Practique Clinique et Investigation (Clinical Practice & Investigation) is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials, clinical practice and clinical research. As a peer-reviewed, tri-annually publication. It provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase 1 trials through to post-marketing studies and pharmaco-economic research.
Each and every year new therapeutic entities enter for clinical use, only one of every 10,000 potential medicines survive the development and approval process. The process of clinical research is highly expensive, involved and complex, with huge demands placed on investigators to deliver robust, reproducible data and to meet the exacting requirements of regulatory authorities.
The scope of the journal: